Exogenous insulin

Exogenous insulin has been studied in 1 paper since 2021: 1 observational study in people. The newest paper, Sep 7, 2021: “Relation between Exogenous Insulin and Cognitive Function in Type 2 Diabetes Mellitus”.

Exposure

1 paper studies it2 findingsUpdated

See all 1 papers on exogenous insulin

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“Age (p = 0.001) and insulin dose (p < 0.0001) were related to the MCI.”
Relation between Exogenous Insulin and Cognitive Function in Type 2 Diabetes MellitusMedicina (Kaunas, Lithuania)2021doi:10.3390/medicina57090943

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Humans1

What did studies of exogenous insulin find?

1

Studies of exogenous insulin measured one outcome, cognitive function.

Cognitive function

upin humans1

1 study
  1. Exogenous insulin is linked with better cognitive function in humans (cross-sectional comparison by insulin requirement group).

    “the results of this study provided evidence that increased exogenous insulin supply improves cognitive function”

    Humanscross-sectional comparison by insulin requirement groupn = 100

    Relation between Exogenous Insulin and Cognitive Function in Type 2 Diabetes Mellitus

    Medicina (Kaunas, Lithuania)

What is exogenous insulin linked with?

1

Studies link exogenous insulin with mild cognitive impairment.

Mild cognitive impairment

mixedin humans1

1 study
  1. Exogenous insulin is associated with mild cognitive impairment in humans (p < 0.0001).

    “Age (p = 0.001) and insulin dose (p < 0.0001) were related to the MCI.”

    Humansn = 100

    Relation between Exogenous Insulin and Cognitive Function in Type 2 Diabetes Mellitus

    Medicina (Kaunas, Lithuania)

More on Mild cognitive impairment

Latest